Hennion & Walsh Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-126,398
| Closed | -$3.41M | – | 805 |
|
|
2022
Q4 | $3.41M | Sell |
126,398
-141,504
| -53% | -$3.72M | 0.21% | 124 |
|
|
2022
Q3 | $4.81M | Sell |
267,902
-11,433
| -4% | -$183K | 0.32% | 71 |
|
|
2022
Q2 | $3.47M | Sell |
279,335
-129,744
| -32% | -$1.43M | 0.22% | 127 |
|
|
2022
Q1 | $5.45M | Sell |
409,079
-25,295
| -6% | -$339K | 0.29% | 88 |
|
|
2021
Q4 | $6.76M | Buy |
434,374
+9,172
| +2% | +$175K | 0.33% | 78 |
|
|
2021
Q3 | $9.54M | Buy |
425,202
+4,922
| +1% | +$108K | 0.5% | 42 |
|
|
2021
Q2 | $9.57M | Buy |
420,280
+20,950
| +5% | +$441K | 0.51% | 37 |
|
|
2021
Q1 | $8.22M | Buy |
+399,330
| New | +$9.09M | 0.49% | 36 |
|